• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中的上皮-间质转化:概述

Epithelial-mesenchymal transition in prostate cancer: an overview.

作者信息

Montanari Micaela, Rossetti Sabrina, Cavaliere Carla, D'Aniello Carmine, Malzone Maria Gabriella, Vanacore Daniela, Di Franco Rossella, La Mantia Elvira, Iovane Gelsomina, Piscitelli Raffaele, Muscariello Raffaele, Berretta Massimiliano, Perdonà Sisto, Muto Paolo, Botti Gerardo, Bianchi Attilio Antonio Montano, Veneziani Bianca Maria, Facchini Gaetano

机构信息

Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy.

Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy.

出版信息

Oncotarget. 2017 May 23;8(21):35376-35389. doi: 10.18632/oncotarget.15686.

DOI:10.18632/oncotarget.15686
PMID:28430640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5471062/
Abstract

Prostate cancer is a main urological disease associated with significant morbidity and mortality. Radical prostatectomy and radiotherapy are potentially curative for localized prostate cancer, while androgen deprivation therapy is the initial systemic therapy for metastatic prostate disease. However, despite temporary response, most patients relapse and evolve into castration resistant cancer.Epithelial-mesenchymal transition (EMT) is a complex gradual process that occurs during embryonic development and/or tumor progression. During this process, cells lose their epithelial characteristics and acquire mesenchymal features. Increasing evidences indicate that EMT promotes prostate cancer metastatic progression and it is closely correlated with increased stemness and drug resistance.In this review, we discuss the main molecular events that directly or indirectly govern the EMT program in prostate cancer, in order to better define the role and the mechanisms underlying this process in prostate cancer progression and therapeutic resistance.

摘要

前列腺癌是一种主要的泌尿系统疾病,与显著的发病率和死亡率相关。根治性前列腺切除术和放射治疗对局限性前列腺癌可能具有治愈性,而雄激素剥夺疗法是转移性前列腺疾病的初始全身治疗方法。然而,尽管有暂时的反应,但大多数患者会复发并演变成去势抵抗性癌症。上皮-间质转化(EMT)是一个复杂的渐进过程,发生在胚胎发育和/或肿瘤进展过程中。在此过程中,细胞失去其上皮特征并获得间质特征。越来越多的证据表明,EMT促进前列腺癌的转移进展,并且与干细胞特性增加和耐药性密切相关。在本综述中,我们讨论直接或间接调控前列腺癌EMT程序的主要分子事件,以便更好地确定这一过程在前列腺癌进展和治疗耐药性中的作用及机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d652/5471062/bb8159fe8d2b/oncotarget-08-35376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d652/5471062/bb8159fe8d2b/oncotarget-08-35376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d652/5471062/bb8159fe8d2b/oncotarget-08-35376-g001.jpg

相似文献

1
Epithelial-mesenchymal transition in prostate cancer: an overview.前列腺癌中的上皮-间质转化:概述
Oncotarget. 2017 May 23;8(21):35376-35389. doi: 10.18632/oncotarget.15686.
2
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.Twist1/AR信号通路介导的上皮-间质转化与前列腺癌去势抵抗之间的串扰
Endocr Relat Cancer. 2015 Dec;22(6):889-900. doi: 10.1530/ERC-15-0225. Epub 2015 Aug 26.
3
Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.前列腺癌中的上皮-间质转化调节因子:雄激素及其他因素
J Steroid Biochem Mol Biol. 2017 Feb;166:84-90. doi: 10.1016/j.jsbmb.2016.05.007. Epub 2016 May 14.
4
Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.前列腺癌治疗反应中上皮-间质转化控制下的细胞死亡
Int J Urol. 2018 Apr;25(4):318-326. doi: 10.1111/iju.13505. Epub 2018 Jan 17.
5
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.雄激素剥夺导致前列腺中的上皮-间充质转化:对雄激素剥夺治疗的影响。
Cancer Res. 2012 Jan 15;72(2):527-36. doi: 10.1158/0008-5472.CAN-11-3004. Epub 2011 Nov 22.
6
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.上皮-间质转化和癌症干细胞在前列腺癌去势抵抗发展中的作用。
Mol Cancer. 2014 Mar 12;13:55. doi: 10.1186/1476-4598-13-55.
7
Profiling Prostate Cancer Therapeutic Resistance.前列腺癌治疗抵抗的特征分析。
Int J Mol Sci. 2018 Mar 19;19(3):904. doi: 10.3390/ijms19030904.
8
CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.在缺氧的雄激素非依赖性前列腺癌细胞中,CX3CL1通过TACE/TGF-α/EGFR途径促进上皮-间质转化,从而增加侵袭性和转移能力。
Oncol Rep. 2016 Feb;35(2):1153-62. doi: 10.3892/or.2015.4470. Epub 2015 Dec 2.
9
Achieving resistance specificity in prostate cancer.实现前列腺癌的耐药特异性。
Chem Biol Interact. 2016 Dec 25;260:243-247. doi: 10.1016/j.cbi.2016.10.002. Epub 2016 Oct 6.
10
Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.肿瘤和基质区域中的音猬因子与雄激素信号传导驱动前列腺癌中的上皮-间质转化。
Scand J Urol. 2014 Dec;48(6):523-32. doi: 10.3109/21681805.2014.898336. Epub 2014 Mar 19.

引用本文的文献

1
The role of SOX transcription factors in prostate cancer: Focusing on SOX2.SOX转录因子在前列腺癌中的作用:聚焦于SOX2
Genes Dis. 2025 May 21;12(6):101692. doi: 10.1016/j.gendis.2025.101692. eCollection 2025 Nov.
2
Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review).上皮-间质转化(EMT)和干性在前列腺癌神经内分泌分化中的广泛激活及关键作用(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8942. Epub 2025 Jul 11.
3
Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer.

本文引用的文献

1
DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties.肺癌中DUOX1基因沉默促进上皮-间质转化、癌症干细胞特性及侵袭性。
Oncogenesis. 2016 Oct 3;5(10):e261. doi: 10.1038/oncsis.2016.61.
2
Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.雌激素信号传导及其介导的受体在前列腺癌中的重要性
Int J Mol Sci. 2016 Aug 31;17(9):1434. doi: 10.3390/ijms17091434.
3
MicroRNAs and epithelial-mesenchymal transition in prostate cancer.微小RNA与前列腺癌中的上皮-间质转化
简而言之:前列腺癌中的信号通路——从发病机制到治疗意义
Ann Med. 2025 Dec;57(1):2474175. doi: 10.1080/07853890.2025.2474175. Epub 2025 May 15.
4
Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data.寡转移前列腺癌的转移导向治疗:生物学原理及已发表数据的系统综述
Cancers (Basel). 2025 Apr 8;17(8):1256. doi: 10.3390/cancers17081256.
5
The role of chloride intracellular channel 4 in tumors.氯离子细胞内通道4在肿瘤中的作用。
Cancer Cell Int. 2025 Mar 26;25(1):118. doi: 10.1186/s12935-025-03737-7.
6
Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells.长期锌治疗会改变前列腺癌细胞的力学性能和代谢。
Cancer Cell Int. 2024 Sep 11;24(1):313. doi: 10.1186/s12935-024-03495-y.
7
Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer.miR-99b-5p与恩杂鲁胺或阿比特龙联合使用可协同抑制前列腺癌中EMT介导的转移。
Cancers (Basel). 2024 May 19;16(10):1933. doi: 10.3390/cancers16101933.
8
Cardiac Glycoside Oleandrin Suppresses EMT Ability in Endometrial Carcinoma Cells.强心苷夹竹桃苷抑制子宫内膜癌细胞的上皮-间质转化能力。
Int J Mol Cell Med. 2023;12(3):220-228. doi: 10.22088/IJMCM.BUMS.12.3.220.
9
Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells.红高粱衍生的脱氧花青素及其O-β-D-葡萄糖苷对PC-3前列腺癌细胞中E-钙黏蛋白启动子活性的影响
Molecules. 2024 Apr 21;29(8):1891. doi: 10.3390/molecules29081891.
10
RNA-binding protein DND1 participates in migration, invasion, and EMT of prostate cancer cells by degrading CLIC4.RNA 结合蛋白 DND1 通过降解 CLIC4 参与前列腺癌细胞的迁移、侵袭和 EMT。
Histol Histopathol. 2024 Oct;39(10):1343-1358. doi: 10.14670/HH-18-720. Epub 2024 Feb 9.
Oncotarget. 2016 Oct 11;7(41):67597-67611. doi: 10.18632/oncotarget.11708.
4
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment.胰腺癌:分子途径与治疗的当前进展
J Cancer. 2016 Jul 7;7(11):1497-514. doi: 10.7150/jca.14922. eCollection 2016.
5
Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX.前列腺癌转化研究中的小鼠模型:从异种移植到患者来源的肿瘤异种移植模型
Biomed Res Int. 2016;2016:9750795. doi: 10.1155/2016/9750795. Epub 2016 May 18.
6
The roles of microRNAs in the progression of castration-resistant prostate cancer.微小RNA在去势抵抗性前列腺癌进展中的作用
J Hum Genet. 2017 Jan;62(1):25-31. doi: 10.1038/jhg.2016.69. Epub 2016 Jun 9.
7
Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway.Twist介导的上皮-间质转化通过抑制Hippo信号通路促进乳腺肿瘤细胞侵袭。
Sci Rep. 2016 Apr 20;6:24606. doi: 10.1038/srep24606.
8
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer.转移性去势抵抗性前列腺癌对新型抗雄激素疗法的耐药性
Clin Med Insights Oncol. 2016 Mar 16;10(Suppl 1):1-9. doi: 10.4137/CMO.S34534. eCollection 2016.
9
Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.在LNCaP前列腺肿瘤异种移植模型中,雄激素剥夺会引发血管变化和缺氧应激,从而促进上皮-间质转化。
Br J Cancer. 2016 Mar 15;114(6):659-68. doi: 10.1038/bjc.2016.29. Epub 2016 Mar 8.
10
Role of EMT in Metastasis and Therapy Resistance.上皮-间质转化在转移和治疗抗性中的作用。
J Clin Med. 2016 Jan 27;5(2):17. doi: 10.3390/jcm5020017.